FNDC5 and metabolic dysfunction-associated steatotic liver disease: It is necessary to investigate the causal effect of irisin signaling in the development of NAFLD in the future studies by controlling the refinement of inclusion criteria strictly, including larger sample size, and designing not only more rigorous but also higher-quality randomized controlled trials, thus providing new methods for the treatment and prediction of irisin levels in association with NAFLD.